NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
This publication is provided for historical reference only and the information may be out of date.
Guide to Clinical Preventive Services, 2nd edition
US Preventive Services Task Force.
The 2nd edition carefully reviews the evidence for and against hundreds of preventive services, recommending a test, immunization, or counseling intervention only when there is evidence that it is effective. At a time when the leading causes of death are largely related to health-related behaviors-including tobacco use, poor diet, lack of physical activity, and alcohol use-it is particularly pertinent to highlight the importance of the health consequences of behavior. It remains extraordinarily important that physicians and other providers educate their patients about these matters.
Although the main audience for the Guide to Clinical Preventive Services is primary care physicians, nurse practitioners, and physician assistants, it will continue to be of great value also to policymakers, researchers, employers, and those in the health care financing community.
Contents
- Foreword
- Preface to the Second Edition
- Preface to the First Edition
- U.S. Preventive Services Task Force
- Task Force Staff
- Acknowledgments
- Introduction
- i. Overview
- Value of Prevention
- Barriers to Preventive Care Delivery
- Historical Perspective
- The Second U.S. Preventive Services Task Force
- Principal Findings of the U.S. Preventive Services Task Force
- A Research Agenda in Preventive Medicine
- Improving the Delivery of Clinical Preventive Services
- REFERENCE, i. Overview
- ii. Methodology
- iii. The Periodic Health Examination: Age-Specific Charts
- iv. Patient Education and Counseling for Prevention
- v. Cost-Effectiveness and Clinical Preventive Services
- Assessing the Cost-Effectiveness of Interventions
- Contexts for the Use of Cost-Effectiveness Analysis: Societal and Clinical
- Cost-Effectiveness Analysis as a Supplement to Information on Effectiveness
- Cost-Effectiveness Analysis and Recommendations for Clinical Preventive Services
- Use of Cost-Effectiveness Analysis in the Absence of Data on Effectiveness
- Cost-Effectiveness of Preventive versus Curative Services
- Current Limits on Use of Cost-Effectiveness Analysis
- Cost-Effectiveness and Task Force Recommendations on Effectiveness
- REFERENCES, v. Cost-Effectiveness
- i. Overview
- Section 1. SCREENING
- 1. Screening for Asymptomatic Coronary Artery Disease
- 2. Screening for High Blood Cholesterol and Other Lipid Abnormalities
- 3. Screening for Hypertension
- 4. Screening for Asymptomatic Carotid Artery Stenosis
- 5. Screening for Peripheral Arterial Disease
- 6. Screening for Abdominal Aortic Aneurysm
- 7. Screening for Breast Cancer
- 8. Screening for Colorectal Cancer
- 9. Screening for Cervical Cancer
- 10. Screening for Prostate Cancer
- 11. Screening for Lung Cancer
- 12. Screening for Skin Cancer— Including Counseling to Prevent Skin Cancer
- 13. Screening for Testicular Cancer
- 14. Screening for Ovarian Cancer
- 15. Screening for Pancreatic Cancer
- 16. Screening for Oral Cancer
- 17. Screening for Bladder Cancer
- 18. Screening for Thyroid Cancer
- 19. Screening for Diabetes Mellitus
- 20. Screening for Thyroid Disease
- 21. Screening for Obesity
- 22. Screening for Iron Deficiency Anemia— Including Iron Prophylaxis
- 23. Screening for Elevated Lead Levels in Childhood and Pregnancy
- 24. Screening for Hepatitis B Virus Infection
- 25. Screening for Tuberculous Infection-- Including Bacille Calmette-Guérin Immunization
- 26. Screening for Syphilis
- 27. Screening for Gonorrhea— Including Ocular Prophylaxis in Newborns
- 28. Screening for Human Immunodeficiency Virus Infection
- 29. Screening for Chlamydial Infection— Including Ocular Prophylaxis in Newborns
- 30. Screening for Genital Herpes Simplex
- 31. Screening for Asymptomatic Bacteriuria
- 32. Screening for Rubella— Including Immunization of Adolescents and Adults
- 33. Screening for Visual Impairment
- 34. Screening for Glaucoma
- 35. Screening for Hearing Impairment
- 36. Screening Ultrasonography in Pregnancy
- 37. Screening for Preeclampsia
- 38. Screening for D (Rh) Incompatibility
- 39. Intrapartum Electronic Fetal Monitoring
- 40. Home Uterine Activity Monitoring
- 41. Screening for Down Syndrome
- 42. Screening for Neural Tube Defects— Including Folic Acid/Folate Prophylaxis
- 43. Screening for Hemoglobinopathies
- 44. Screening for Phenylketonuria
- 45. Screening for Congenital Hypothyroidism
- 46. Screening for Postmenopausal Osteoporosis
- 47. Screening for Adolescent Idiopathic Scoliosis
- 48. Screening for Dementia
- 49. Screening for Depression
- 50. Screening for Suicide Risk
- 51. Screening for Family Violence
- 52. Screening for Problem Drinking
- 53. Screening for Drug Abuse
- Section 2. COUNSELING
- 54. Counseling to Prevent Tobacco Use
- 55. Counseling to Promote Physical Activity
- 56. Counseling to Promote a Healthy Diet
- 57. Counseling to Prevent Motor Vehicle Injuries
- 58. Counseling to Prevent Household and Recreational Injuries
- 59. Counseling to Prevent Youth Violence
- 60. Counseling to Prevent Low Back Pain
- 61. Counseling to Prevent Dental and Periodontal Disease
- 62. Counseling to Prevent HIV Infection and Other Sexually Transmitted Diseases
- 63. Counseling to Prevent Unintended Pregnancy
- 64. Counseling to Prevent Gynecologic Cancers
- Section 3. IMMUNIZATIONS AND CHEMOPROPHYLAXIS
- 65. Childhood Immunizations
- 66. Adult Immunizations— Including Chemoprophylaxis Against Influenza A
- 67. Postexposure Prophylaxis for Selected Infectious Diseases
- 68. Postmenopausal Hormone Prophylaxis
- 69. Aspirin Prophylaxis for the Primary Prevention of Myocardial Infarction
- 70. Aspirin Prophylaxis in Pregnancy
- Appendices
- Guide to Clinical Preventive ServicesGuide to Clinical Preventive Services
Your browsing activity is empty.
Activity recording is turned off.
See more...